Food and Drug Administration link Xolair to heart problems

The FDA  announced that the asthma drug Xolair may increase the risk of patients developing a host of cardiovascular problems. Data gathered from clinic trials showed that Xolair users were disproportionately more likely to suffer from blood clots, heart failure, stroke, cardiac arrhythmias and heart enlargement

One Reply to “Food and Drug Administration link Xolair to heart problems”

Comments are closed.